PARACETAMOL POISONING
DR VIVEK BENJAMIN,MD
HISTORY OF PARACETAMOL
1880s University of Strasburg,Professor Adolf Kussmaul and his two
young assistants, Arnold Cahn and Paul Hepp, experimented with
phenacetin.
Phenacetin was widely used for about 90 years until
mounting concerns over carcinogecity and
kidney damaging properties.
• In 1887, the Bayer company introduced the 4-
ethoxy derivative, phenacetin, as a less toxic
analogue of Acetanilide.
• In 1889 it was demonstrated that paracetamol
was a urinary metabolite of acetanilide. These
discoveries, however, failed to attract much
attention and were largely ignored at the time.
• It 1948-1949, Brodie and Axelrod discovered that
paracetamol was the main metabolite of both
acetanilide and phenacetin,
N-acetyl-p-benzoquinone
imine
PARACETAMOL OVERDOSE
- Most common drug taken in overdose
- Few symptoms or early signs
- As little as 12g can be fatal
2
CHARACTERISTICS OF ACETAMINOPHEN
- White solid crystals
- Lightly soluble in cold water
- Greater solubility in hot water
- Solubility in organic solvents
- Soluble in menthol
ACETAMINOPHEN’S
Pharmaceutical Classes
 Classification
 Derivative of
acetanilide
 Analgesic
 Non-narcotic
 Antipyretic
NON
TOXIC
Non toxic
Toxic
MINOR ROUTE
Phase 1 reaction
Oxidized by hepatic cytochrome P450 enzymes
Form n-acetyl-p- benzoquinoneimine (NAPQI)
Main metabolism
PHASE 2 REACTION
Conjugation with sulfate and glucuronide to
form nontoxic metabolites in liver
NAPQI
Toxic by product
Detoxified by conjugation with glutathione
Mercapturic acid
harmless and water-soluble
renal excretion
 HOWEVER UNDER SOME CONDITION
e.g acetaminophen intoxication
NAPQI is not effectively detoxified
Cause severe damage to the liver tissues
PARACETAMOL > 140 MG/KG BODY WEIGHT
 Sulfate and glucuronide pathways saturated
 Increased amount of paracetamol gets metabolized to
NAPQI
 Glutathione levelsdepleted
 Free NAPQI leads to centrilobular necrosis
LOW GLUTATHIONE LEVELS
Hepatic necrosis occurs only when concentrations
of reduced glutathione fall below a critical level
1
 With increased paracetamol doses, greater production of NAPQI
may deplete glutathione stores.
 When glutathione depletion reaches a critical level (thought to
be about 30% of normal stores), NAPQI binds to other proteins,
causing damage to the hepatocyte.
 Glutathione depletion itself may also be injurious.
THE CLINICAL COURSE OF ACETAMINOPHEN TOXICITY
Divided into 4 phases.
Physical findings vary, depending primarily on the level of hepatotoxicity.
May not exist for mild poisoning
PHASE 1
•  0.5-24 hours afteringestion
•  Patientsmaybe asymptomaticorreport anorexia,nausea or
vomiting,and malaise
•  Physicalexamination mayreveal
pallor, diaphoresis,malaise, and
fatigue
PHASE 2
18-72 h after ingestion
Patients generally develop right upper quadrant abdominal
pain, anorexia, nausea,
and vomiting
Right upper quadrant
tenderness may be present
15
PHASE 2 (CONT)
• Tachycardia and hypotension indicate ongoing volume losses
• Some patients may report decreased urinary output (oliguria)
PHASE 3 : HEPATIC PHASE
72-96 h afteringestion
Patients may have continued nausea and vomiting, abdominal
pain, and a tender hepatic edge
Hepatic necrosis and dysfunction are associated with
jaundice, coagulopathy, hypoglycemia, and hepatic
encephalopathy
 ALT - often between 2000 and 10,000 U/L
 Acute renal failure develops in some critically ill patients
Death from multiorgan failure may occur
PHASE 4 : RECOVERY PHASE
 4 days to 3 weeks after ingestion
 Patients who survive critical illness in phase 3 have
complete resolution of symptoms and complete
resolution of organ failure
OTHER CONSEQUENCES OF
Severe Toxicity
 Hepatic Encephalopathy
 Grade III – Confusion
 Grade IV – Coma
GLUTATHIONE
• Most important antioxidant in the liver
• Liver is the only site of glutathione synthesis
TOXIC DOSE OF PARACETAMOL
 Single ingestion > 7 to 10 g (150 mg/kg body weight in children)
 Fatal cases usually involve doses of at least 15 to 25 g
 In heavy drinkers, daily doses of 2 to 6 g have been associated with fatal
hepatotoxicity
Plasma half-life of paracetamol
2 to 4 hours
SIGNS AND SYMPTOMS
 Most patients who have taken an overdose of acetaminophen
will initially be asymptomatic, as clinical evidence of end-organ
toxicity often does not manifest until 24-48 hours after an acute
ingestion.
 Minimum toxic doses for a single ingestion, posing significant
risk of severe hepatotoxicity, are as follows:
 Adults: 7.5-10 g
 Children: 150 mg/kg; 200 mg/kg in healthy children aged 1-6
years
BLOOD INVESTIGATIONS :
Bloodglucose
Blood & Urine toxicology screening
serum PCMlevel
(>200 μg/mLmeasured at 4 h or >100 μg/mLat
8 h after ingestion)
RP,LFT,ABG, coag profile
MOST IMPORTANT FACTOR AFFECTING
MORTALITY
Time of presentation – cysteine within 12
hours abolishes significant liver injury
OTHER PROGNOSTIC FACTORS
• Age
• Alcohol
• Malnutrition
• Fasting
AGE
• Children have faster turnover rate of glutathione or
increased sulphate conjugation, hence why they
might be less likely to get hepatotoxicity
(butdecreased glucuronidationcapacity)
ALCOHOL
Induces cytochrome P450
Chronic alcoholics – toxic dose of paracetamol may
be as low as 2 grams
Malnutrition
DECREASES GLUTATHIONE RESERVES
FASTING
• Fasting patients are high risk since 4g-10g can easily
induce hepatotoxicity
INDICATORS OF A POOR OUTCOME
Grade IV hepatic coma
Acidosis - pH less than 7.30
PT- prolongation
Renal failure - Serum creatinine > 3.3
FallingALT with worsening PT
MANAGEMENT
If < 8 hours :
Tx of choice – activated charcoal 1g/kg
Check ROUTINE along with LFT,ABG, Drug levels at 4
hours post-ingestion
If 8-24 hours & suspicious of large overdose (> 7.5g ) :
Start NAC
IF UNKNOWN TIME OF OVERDOSE
• Determine serum acetaminophen levels (acetaminophen
concentration >10 mcg/mL (66 μmol/L).
• Determine INR levels, RFT, LFT
• Treat with Acetylcysteine if serum Acetaminophen or
transaminases (ALT, AST) are elevated.
MANAGEMENT
Monitor
- GCS, BP, ECG, oxygenation
Supportive
- correct hypoxia, hypotension, acidosis, dehydration
Antidots
- NAC
- Methionine
42
TREATMENT
 Two treatment methods
 Activated Charcoal
 Works by absorbing unabsorbed drug in the stomach
 N-acetylcysteine (NAC)
 Works by increasing hepatic glutathione stores.
43
N-ACETYLCYSTEINE
 Antidote of choice
 Oral
 Loading dose 140mg/kg
 Maintenance dose 70 mg/kg every 4 hours for
17 doses
 NAC BYIV INFUSIONS :
Loading dose : 150mg/kg in 5% Dextrose over 15 mins
Followed by : 50mg/kg in 500 ml of D5 over 4H then
100mg/kg/16H in 1L of D5
SIDE EFFECTS OF NAC
 Rash – common
Txwith Chlorpheneramine + observe
Nausea, vomiting, and epigastric discomfort
 Wheeze (occur <10%)
 Fatal shock
METHIONINE
In patients known to be sensitized to NAC
Give : oral 2.5g/4H for 16H (total 10g)
ONGOING MANAGEMENT
Blood ixon the next day :
INR (if still PT high, cont NAC)
Renal Profile
Liver Function Test
Liver transplantation
If signs of hepatic failure (e.g., progressive jaundice,coagulopathy, confusion)
occur despite Nacetylcysteine therapy for acetaminophen hepatotoxicity, liver
transplantation may be the only option.
The United Kingdom King's College Hospital criteria for the determination of
the urgent need for transplantation after acetaminophen-induced fulminant
hepatic failure include any one of the following:
Arterial pH less than 7.3 after fluid
resuscitation(lactate levels >3.5 mmol/L)
Grade III or IV encephalopathy
Prothrombin time (PT) greater than 100 seconds
Serum creatinine level greater than 3.4 mg/dL
PATIENT EDUCATION
 Patient should not take over 4 grams of
Acetaminophen/day.
 Threshold may be lower for patients with liver
disease or cirrhosis
 Increased risk of hepatotoxicity with chronic alcohol use
THANK YOU
 1. Oxford Handbook of Clinical Medicine 9th Ed.
 2. Sarawak Handbook of Medical Emergencies 3rd Edition
 3. http://emedicine.medscape.com/article/820200-overview
 4. http://www.nhs.uk/Conditions/Poisoning/Pages/Symptoms.aspx
 5. https://www.mja.com.au/journal/2008/188/5/guidelines-
management-
paracetamol-poisoning-australia-and-new-zealand-explanation

Paracetamol poisoning

  • 1.
  • 2.
    HISTORY OF PARACETAMOL 1880sUniversity of Strasburg,Professor Adolf Kussmaul and his two young assistants, Arnold Cahn and Paul Hepp, experimented with phenacetin. Phenacetin was widely used for about 90 years until mounting concerns over carcinogecity and kidney damaging properties.
  • 3.
    • In 1887,the Bayer company introduced the 4- ethoxy derivative, phenacetin, as a less toxic analogue of Acetanilide. • In 1889 it was demonstrated that paracetamol was a urinary metabolite of acetanilide. These discoveries, however, failed to attract much attention and were largely ignored at the time. • It 1948-1949, Brodie and Axelrod discovered that paracetamol was the main metabolite of both acetanilide and phenacetin,
  • 10.
  • 14.
    PARACETAMOL OVERDOSE - Mostcommon drug taken in overdose - Few symptoms or early signs - As little as 12g can be fatal 2
  • 15.
    CHARACTERISTICS OF ACETAMINOPHEN -White solid crystals - Lightly soluble in cold water - Greater solubility in hot water - Solubility in organic solvents - Soluble in menthol
  • 16.
    ACETAMINOPHEN’S Pharmaceutical Classes  Classification Derivative of acetanilide  Analgesic  Non-narcotic  Antipyretic
  • 17.
  • 18.
    MINOR ROUTE Phase 1reaction Oxidized by hepatic cytochrome P450 enzymes Form n-acetyl-p- benzoquinoneimine (NAPQI)
  • 19.
    Main metabolism PHASE 2REACTION Conjugation with sulfate and glucuronide to form nontoxic metabolites in liver
  • 20.
    NAPQI Toxic by product Detoxifiedby conjugation with glutathione Mercapturic acid harmless and water-soluble renal excretion
  • 21.
     HOWEVER UNDERSOME CONDITION e.g acetaminophen intoxication NAPQI is not effectively detoxified Cause severe damage to the liver tissues
  • 22.
    PARACETAMOL > 140MG/KG BODY WEIGHT  Sulfate and glucuronide pathways saturated  Increased amount of paracetamol gets metabolized to NAPQI  Glutathione levelsdepleted  Free NAPQI leads to centrilobular necrosis
  • 23.
    LOW GLUTATHIONE LEVELS Hepaticnecrosis occurs only when concentrations of reduced glutathione fall below a critical level 1
  • 24.
     With increasedparacetamol doses, greater production of NAPQI may deplete glutathione stores.  When glutathione depletion reaches a critical level (thought to be about 30% of normal stores), NAPQI binds to other proteins, causing damage to the hepatocyte.  Glutathione depletion itself may also be injurious.
  • 25.
    THE CLINICAL COURSEOF ACETAMINOPHEN TOXICITY Divided into 4 phases. Physical findings vary, depending primarily on the level of hepatotoxicity. May not exist for mild poisoning
  • 26.
    PHASE 1 • 0.5-24 hours afteringestion •  Patientsmaybe asymptomaticorreport anorexia,nausea or vomiting,and malaise •  Physicalexamination mayreveal pallor, diaphoresis,malaise, and fatigue
  • 27.
    PHASE 2 18-72 hafter ingestion Patients generally develop right upper quadrant abdominal pain, anorexia, nausea, and vomiting Right upper quadrant tenderness may be present 15
  • 28.
    PHASE 2 (CONT) •Tachycardia and hypotension indicate ongoing volume losses • Some patients may report decreased urinary output (oliguria)
  • 29.
    PHASE 3 :HEPATIC PHASE 72-96 h afteringestion Patients may have continued nausea and vomiting, abdominal pain, and a tender hepatic edge Hepatic necrosis and dysfunction are associated with jaundice, coagulopathy, hypoglycemia, and hepatic encephalopathy  ALT - often between 2000 and 10,000 U/L  Acute renal failure develops in some critically ill patients Death from multiorgan failure may occur
  • 30.
    PHASE 4 :RECOVERY PHASE  4 days to 3 weeks after ingestion  Patients who survive critical illness in phase 3 have complete resolution of symptoms and complete resolution of organ failure
  • 31.
    OTHER CONSEQUENCES OF SevereToxicity  Hepatic Encephalopathy  Grade III – Confusion  Grade IV – Coma
  • 32.
    GLUTATHIONE • Most importantantioxidant in the liver • Liver is the only site of glutathione synthesis
  • 33.
    TOXIC DOSE OFPARACETAMOL  Single ingestion > 7 to 10 g (150 mg/kg body weight in children)  Fatal cases usually involve doses of at least 15 to 25 g  In heavy drinkers, daily doses of 2 to 6 g have been associated with fatal hepatotoxicity
  • 34.
    Plasma half-life ofparacetamol 2 to 4 hours
  • 35.
    SIGNS AND SYMPTOMS Most patients who have taken an overdose of acetaminophen will initially be asymptomatic, as clinical evidence of end-organ toxicity often does not manifest until 24-48 hours after an acute ingestion.  Minimum toxic doses for a single ingestion, posing significant risk of severe hepatotoxicity, are as follows:  Adults: 7.5-10 g  Children: 150 mg/kg; 200 mg/kg in healthy children aged 1-6 years
  • 36.
    BLOOD INVESTIGATIONS : Bloodglucose Blood& Urine toxicology screening serum PCMlevel (>200 μg/mLmeasured at 4 h or >100 μg/mLat 8 h after ingestion) RP,LFT,ABG, coag profile
  • 37.
    MOST IMPORTANT FACTORAFFECTING MORTALITY Time of presentation – cysteine within 12 hours abolishes significant liver injury
  • 38.
    OTHER PROGNOSTIC FACTORS •Age • Alcohol • Malnutrition • Fasting
  • 39.
    AGE • Children havefaster turnover rate of glutathione or increased sulphate conjugation, hence why they might be less likely to get hepatotoxicity (butdecreased glucuronidationcapacity)
  • 40.
    ALCOHOL Induces cytochrome P450 Chronicalcoholics – toxic dose of paracetamol may be as low as 2 grams
  • 41.
  • 42.
    FASTING • Fasting patientsare high risk since 4g-10g can easily induce hepatotoxicity
  • 43.
    INDICATORS OF APOOR OUTCOME Grade IV hepatic coma Acidosis - pH less than 7.30 PT- prolongation Renal failure - Serum creatinine > 3.3 FallingALT with worsening PT
  • 44.
    MANAGEMENT If < 8hours : Tx of choice – activated charcoal 1g/kg Check ROUTINE along with LFT,ABG, Drug levels at 4 hours post-ingestion If 8-24 hours & suspicious of large overdose (> 7.5g ) : Start NAC
  • 45.
    IF UNKNOWN TIMEOF OVERDOSE • Determine serum acetaminophen levels (acetaminophen concentration >10 mcg/mL (66 μmol/L). • Determine INR levels, RFT, LFT • Treat with Acetylcysteine if serum Acetaminophen or transaminases (ALT, AST) are elevated.
  • 46.
    MANAGEMENT Monitor - GCS, BP,ECG, oxygenation Supportive - correct hypoxia, hypotension, acidosis, dehydration Antidots - NAC - Methionine 42
  • 47.
    TREATMENT  Two treatmentmethods  Activated Charcoal  Works by absorbing unabsorbed drug in the stomach  N-acetylcysteine (NAC)  Works by increasing hepatic glutathione stores. 43
  • 48.
    N-ACETYLCYSTEINE  Antidote ofchoice  Oral  Loading dose 140mg/kg  Maintenance dose 70 mg/kg every 4 hours for 17 doses
  • 49.
     NAC BYIVINFUSIONS : Loading dose : 150mg/kg in 5% Dextrose over 15 mins Followed by : 50mg/kg in 500 ml of D5 over 4H then 100mg/kg/16H in 1L of D5
  • 51.
    SIDE EFFECTS OFNAC  Rash – common Txwith Chlorpheneramine + observe Nausea, vomiting, and epigastric discomfort  Wheeze (occur <10%)  Fatal shock
  • 52.
    METHIONINE In patients knownto be sensitized to NAC Give : oral 2.5g/4H for 16H (total 10g)
  • 53.
    ONGOING MANAGEMENT Blood ixonthe next day : INR (if still PT high, cont NAC) Renal Profile Liver Function Test
  • 54.
    Liver transplantation If signsof hepatic failure (e.g., progressive jaundice,coagulopathy, confusion) occur despite Nacetylcysteine therapy for acetaminophen hepatotoxicity, liver transplantation may be the only option. The United Kingdom King's College Hospital criteria for the determination of the urgent need for transplantation after acetaminophen-induced fulminant hepatic failure include any one of the following: Arterial pH less than 7.3 after fluid resuscitation(lactate levels >3.5 mmol/L) Grade III or IV encephalopathy Prothrombin time (PT) greater than 100 seconds Serum creatinine level greater than 3.4 mg/dL
  • 55.
    PATIENT EDUCATION  Patientshould not take over 4 grams of Acetaminophen/day.  Threshold may be lower for patients with liver disease or cirrhosis  Increased risk of hepatotoxicity with chronic alcohol use
  • 56.
    THANK YOU  1.Oxford Handbook of Clinical Medicine 9th Ed.  2. Sarawak Handbook of Medical Emergencies 3rd Edition  3. http://emedicine.medscape.com/article/820200-overview  4. http://www.nhs.uk/Conditions/Poisoning/Pages/Symptoms.aspx  5. https://www.mja.com.au/journal/2008/188/5/guidelines- management- paracetamol-poisoning-australia-and-new-zealand-explanation